Literature DB >> 26295589

Overcoming difficulty in diagnosis and differential diagnosis of Crohn's disease: the potential role of serological and genetic tests.

Zhaoxiu Liu1, Bo Shen.   

Abstract

Crohn's disease (CD) represents a heterogeneous group of chronic inflammatory disorders with various phenotypes. Establishing a definite diagnosis of CD should be based upon a combined assessment of clinical, endoscopic, radiological and pathological features. Although segmental disease distribution, transmural inflammation and non-caseating epithelioid granulomas have been considered as a 'hallmarks' for CD, clear diagnosis of CD in some patients has been challenging, due to overlapping endoscopic, radiographic and histologic features with other inflammatory bowel disease-like conditions. Laboratory markers (serological and genetic tests) may provide additional clues for the diagnosis and differential diagnosis of CD. This review focuses on the application of the currently available serological and genomic markers and in diagnosis and differential diagnosis of CD.

Entities:  

Keywords:  Crohn’s disease; biomarkers; diagnosis; differential diagnosis; genetic testing; inflammatory bowel disease; serology

Mesh:

Substances:

Year:  2015        PMID: 26295589     DOI: 10.1586/14737159.2015.1068121

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  2 in total

1.  ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Authors:  Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2018-03-27       Impact factor: 10.864

2.  National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.

Authors:  Yasuhiro Kanatani; Naoko Tomita; Yoko Sato; Akiko Eto; Hiroe Omoe; Hiroshi Mizushima
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-09-21       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.